id	sid	eid	entity	type
dpc-4769	2	1	1	CARDINAL
dpc-4769	2	2	tildrakizumab 200 mg	LAW
dpc-4769	3	1	eugenia veronica di brizzi1	PERSON
dpc-4769	3	2	caccavale1	PERSON
dpc-4769	3	3	roberta di caprio1	PERSON
dpc-4769	3	4	francesco cusano2	PERSON
dpc-4769	3	5	rocco de pasquale3	PERSON
dpc-4769	3	6	valeria falcomatà4	PERSON
dpc-4769	3	7	foti5	GPE
dpc-4769	3	8	claudia giofrè6	PERSON
dpc-4769	3	9	emanuela gubinelli7	PERSON
dpc-4769	3	10	mazzocchetti8	PERSON
dpc-4769	3	11	giovanni palazzo10	PERSON
dpc-4769	3	12	leonardo pescitelli11	PERSON
dpc-4769	3	13	rosa valentina puca12	PERSON
dpc-4769	3	14	sarno12	ORG
dpc-4769	3	15	anna balato1 1	PERSON
dpc-4769	3	16	university of campania	ORG
dpc-4769	3	17	2	CARDINAL
dpc-4769	3	18	san pio hospital	ORG
dpc-4769	3	19	benevento	GPE
dpc-4769	3	20	italy 3	ORG
dpc-4769	3	21	u.o.	GPE
dpc-4769	3	22	dermatologia	ORG
dpc-4769	3	23	ospedale san marco	ORG
dpc-4769	3	24	catania	GPE
dpc-4769	3	25	bianchi melacrino morelli	ORG
dpc-4769	3	26	reggio calabria	ORG
dpc-4769	3	27	italy 5	EVENT
dpc-4769	3	28	italy 6	FAC
dpc-4769	3	29	messina	GPE
dpc-4769	3	30	italy 7 istituto dermopatico dell’immacolata	ORG
dpc-4769	3	31	rome	GPE
dpc-4769	3	32	italy 8	ORG
dpc-4769	3	33	asl1 pescara	PERSON
dpc-4769	3	34	65124	DATE
dpc-4769	3	35	pescara	PERSON
dpc-4769	3	36	italy	GPE
dpc-4769	3	37	carlo urbani hospital	PERSON
dpc-4769	3	38	jesi	GPE
dpc-4769	3	39	ancona	GPE
dpc-4769	3	40	italy	GPE
dpc-4769	3	41	10	CARDINAL
dpc-4769	3	42	ospedale distrettuale “a. lo dico	ORG
dpc-4769	3	43	matera	GPE
dpc-4769	3	44	italy 11	ORG
dpc-4769	3	45	university of florence	ORG
dpc-4769	3	46	florence	GPE
dpc-4769	3	47	italy 12	ORG
dpc-4769	3	48	san giuseppe moscati	PERSON
dpc-4769	3	49	83100	DATE
dpc-4769	3	50	avellino	GPE
dpc-4769	3	51	italy	GPE
dpc-4769	3	52	anti-il23	PERSON
dpc-4769	3	53	di brizzi ev	PERSON
dpc-4769	3	54	caccavale s	PERSON
dpc-4769	3	55	di caprio	PERSON
dpc-4769	4	1	tildrakizumab 200 mg	LAW
dpc-4769	7	1	https://doi.org/10.5826/	ORG
dpc-4769	7	2	september 25, 2024	DATE
dpc-4769	7	3	october 2024	DATE
dpc-4769	8	1	2024	CARDINAL
dpc-4769	9	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-4769	13	1	eugenia veronica di brizzi	PERSON
dpc-4769	13	2	md	GPE
dpc-4769	13	3	university of campania	ORG
dpc-4769	13	4	5	CARDINAL
dpc-4769	13	5	80131	DATE
dpc-4769	13	6	italy	GPE
dpc-4769	14	1	2	CARDINAL
dpc-4769	15	1	2-4%	PERCENT
dpc-4769	15	2	1,2	CARDINAL
dpc-4769	18	1	3	CARDINAL
dpc-4769	19	1	4,5	CARDINAL
dpc-4769	21	1	6,7	CARDINAL
dpc-4769	22	1	8	CARDINAL
dpc-4769	24	1	23	CARDINAL
dpc-4769	25	1	th17	PRODUCT
dpc-4769	26	1	100-mg	QUANTITY
dpc-4769	26	2	week 4	DATE
dpc-4769	26	3	every 12 weeks	DATE
dpc-4769	27	1	european	NORP
dpc-4769	27	2	200 mg	QUANTITY
dpc-4769	27	3	11	CARDINAL
dpc-4769	28	1	12,13,14	CARDINAL
dpc-4769	30	1	200 mg	QUANTITY
dpc-4769	30	2	tildrakizumab	ORG
dpc-4769	30	3	12	CARDINAL
dpc-4769	31	1	200 mg	QUANTITY
dpc-4769	31	2	tildrakizumab	ORG
dpc-4769	32	1	march 2023 to march 2024	DATE
dpc-4769	32	2	13	CARDINAL
dpc-4769	32	3	italian	NORP
dpc-4769	33	1	helsinki	PERSON
dpc-4769	34	1	age ≥ 18 years	DATE
dpc-4769	34	2	tildrakizumab	PERSON
dpc-4769	34	3	23	CARDINAL
dpc-4769	35	1	200 mg	QUANTITY
dpc-4769	35	2	tildrakizumab	ORG
dpc-4769	36	1	54	CARDINAL
dpc-4769	36	2	march 2023 to march 2024	DATE
dpc-4769	36	3	13	CARDINAL
dpc-4769	36	4	italian	NORP
dpc-4769	38	1	pasi	PERSON
dpc-4769	38	2	bsa	ORG
dpc-4769	38	3	weeks 4, 16	DATE
dpc-4769	38	4	28	CARDINAL
dpc-4769	40	1	week 16	DATE
dpc-4769	41	1	week 4	DATE
dpc-4769	41	2	0.001	CARDINAL
dpc-4769	41	3	weeks 16	DATE
dpc-4769	41	4	3.9 ± 4.2	CARDINAL
dpc-4769	41	5	0.001	CARDINAL
dpc-4769	41	6	28	CARDINAL
dpc-4769	41	7	2.9 ± 4.4	CARDINAL
dpc-4769	41	8	0.001	CARDINAL
dpc-4769	42	1	30	CARDINAL
dpc-4769	42	2	4.333	CARDINAL
dpc-4769	42	3	0.05	CARDINAL
dpc-4769	42	4	100 mg	QUANTITY
dpc-4769	44	1	tildrakizumab 200 mg	LAW
dpc-4769	47	1	3	CARDINAL
dpc-4769	48	1	the last five years	DATE
dpc-4769	53	1	4, week 16, and week 28	DATE
dpc-4769	55	1	bsa	ORG
dpc-4769	55	2	weeks 4	DATE
dpc-4769	55	3	16	DATE
dpc-4769	55	4	28	CARDINAL
dpc-4769	56	1	28	CARDINAL
dpc-4769	57	1	aes	ORG
dpc-4769	57	2	aes	ORG
dpc-4769	57	3	aes	ORG
dpc-4769	57	4	aes	ORG
dpc-4769	58	1	aes	ORG
dpc-4769	59	1	aes	ORG
dpc-4769	59	2	weeks 4, 16	DATE
dpc-4769	59	3	28	CARDINAL
dpc-4769	63	1	tildrakizumab 200 mg	LAW
dpc-4769	63	2	pasi	ORG
dpc-4769	63	3	bsa	ORG
dpc-4769	64	1	less than 0.05	CARDINAL
dpc-4769	65	1	6.0	CARDINAL
dpc-4769	65	2	graphpad software inc.	ORG
dpc-4769	65	3	la jolla	GPE
dpc-4769	65	4	sas®	ORG
dpc-4769	65	5	9.3	CARDINAL
dpc-4769	65	6	sas institute inc.	ORG
dpc-4769	65	7	cary	GPE
dpc-4769	65	8	nc	GPE
dpc-4769	66	1	54	CARDINAL
dpc-4769	66	2	36	CARDINAL
dpc-4769	66	3	66.7%	PERCENT
dpc-4769	66	4	12.6 years	DATE
dpc-4769	66	5	18.3 ±	PERCENT
dpc-4769	66	6	10.9 years	DATE
dpc-4769	67	1	54	CARDINAL
dpc-4769	67	2	52	CARDINAL
dpc-4769	67	3	44	DATE
dpc-4769	67	4	32	CARDINAL
dpc-4769	67	5	at least 4	CARDINAL
dpc-4769	67	6	16	DATE
dpc-4769	67	7	28 weeks	DATE
dpc-4769	68	1	n=30	ORG
dpc-4769	68	2	55.6%	PERCENT
dpc-4769	68	3	51.8.2%	PERCENT
dpc-4769	68	4	50%	PERCENT
dpc-4769	68	5	n=8	ORG
dpc-4769	68	6	14.8%	PERCENT
dpc-4769	68	7	n=5	PERSON
dpc-4769	68	8	9.3%	PERCENT
dpc-4769	68	9	n=3,5.6%	PERCENT
dpc-4769	68	10	1.8%	PERCENT
dpc-4769	69	1	1	CARDINAL
dpc-4769	69	2	15.9 ± 8.9	CARDINAL
dpc-4769	69	3	bsa	ORG
dpc-4769	69	4	17.9 ±	CARDINAL
dpc-4769	69	5	15.3 ±	CARDINAL
dpc-4769	70	1	14	DATE
dpc-4769	70	2	25.9%	PERCENT
dpc-4769	70	3	11	CARDINAL
dpc-4769	70	4	20.3%	PERCENT
dpc-4769	70	5	10	CARDINAL
dpc-4769	70	6	18.5%	PERCENT
dpc-4769	70	7	9	CARDINAL
dpc-4769	70	8	16.7%	PERCENT
dpc-4769	70	9	3 (5.5%	PERCENT
dpc-4769	71	1	13	CARDINAL
dpc-4769	71	2	24.1%	PERCENT
dpc-4769	72	1	at least one	CARDINAL
dpc-4769	72	2	31	DATE
dpc-4769	73	1	57.4%	PERCENT
dpc-4769	73	2	nb	ORG
dpc-4769	73	3	19	CARDINAL
dpc-4769	74	1	35.2%	PERCENT
dpc-4769	74	2	16	CARDINAL
dpc-4769	75	1	29.6%	PERCENT
dpc-4769	75	2	acitretin 16	PERSON
dpc-4769	76	1	29.6%	PERCENT
dpc-4769	76	2	anti-tnf	NORP
dpc-4769	76	3	19	CARDINAL
dpc-4769	76	4	35.2%	PERCENT
dpc-4769	76	5	5	CARDINAL
dpc-4769	77	1	9.3%	PERCENT
dpc-4769	77	2	2	CARDINAL
dpc-4769	77	3	3.7%	PERCENT
dpc-4769	77	4	2	CARDINAL
dpc-4769	78	1	3.7%	PERCENT
dpc-4769	78	2	16.7%	PERCENT
dpc-4769	78	3	12.9%	PERCENT
dpc-4769	78	4	3	CARDINAL
dpc-4769	78	5	5.6%	PERCENT
dpc-4769	79	1	5.6%	PERCENT
dpc-4769	79	2	3	CARDINAL
dpc-4769	79	3	5.6%	PERCENT
dpc-4769	79	4	2	CARDINAL
dpc-4769	79	5	3.7%	PERCENT
dpc-4769	80	1	19	CARDINAL
dpc-4769	80	2	35.19%	PERCENT
dpc-4769	80	3	200 mg	QUANTITY
dpc-4769	81	1	only 13	CARDINAL
dpc-4769	81	2	24.1%	PERCENT
dpc-4769	81	3	bio-naïve	PERSON
dpc-4769	81	4	1	CARDINAL
dpc-4769	83	1	aes	ORG
dpc-4769	84	1	aes	ORG
dpc-4769	84	2	1/54	CARDINAL
dpc-4769	84	3	the day	DATE
dpc-4769	85	1	9 ± 6.9	CARDINAL
dpc-4769	85	2	0.001	CARDINAL
dpc-4769	85	3	week 4	DATE
dpc-4769	85	4	weeks 16	DATE
dpc-4769	85	5	3.9 ± 4.2	CARDINAL
dpc-4769	85	6	0.001	CARDINAL
dpc-4769	85	7	28	CARDINAL
dpc-4769	85	8	2.9	CARDINAL
dpc-4769	85	9	0.001	CARDINAL
dpc-4769	85	10	1	CARDINAL
dpc-4769	86	1	bsa	ORG
dpc-4769	87	1	1	CARDINAL
dpc-4769	88	1	24	CARDINAL
dpc-4769	88	2	up to 16 weeks	DATE
dpc-4769	88	3	4	CARDINAL
dpc-4769	89	1	week 16	DATE
dpc-4769	90	1	4.333	CARDINAL
dpc-4769	90	2	95%	PERCENT
dpc-4769	90	3	1.435	CARDINAL
dpc-4769	90	4	6.00	CARDINAL
dpc-4769	90	5	0.05	CARDINAL
dpc-4769	91	1	greater than two years	DATE
dpc-4769	91	2	week 16	DATE
dpc-4769	91	3	4.51	CARDINAL
dpc-4769	91	4	95%	PERCENT
dpc-4769	91	5	2.891–5.923	CARDINAL
dpc-4769	91	6	0.001	CARDINAL
dpc-4769	92	1	3.8	CARDINAL
dpc-4769	92	2	95%	PERCENT
dpc-4769	92	3	1.193–5.530	CARDINAL
dpc-4769	92	4	0.05	CARDINAL
dpc-4769	93	1	tildrakizumab 100	LAW
dpc-4769	93	2	week 16	DATE
dpc-4769	93	3	3.00	CARDINAL
dpc-4769	93	4	95%	PERCENT
dpc-4769	93	5	0.8482	CARDINAL
dpc-4769	93	6	5.305	CARDINAL
dpc-4769	93	7	0.05	CARDINAL
dpc-4769	96	1	45-65	DATE
dpc-4769	96	2	under 45	DATE
dpc-4769	96	3	over 65	CARDINAL
dpc-4769	96	4	under 45	DATE
dpc-4769	97	1	between 25 and 30	CARDINAL
dpc-4769	98	1	more than two	CARDINAL
dpc-4769	98	2	5	CARDINAL
dpc-4769	98	3	fewer than two	CARDINAL
dpc-4769	100	1	greater than 10	CARDINAL
dpc-4769	100	2	less than 10	CARDINAL
dpc-4769	101	1	acitretin	PERSON
dpc-4769	102	1	fewer than two	CARDINAL
dpc-4769	102	2	more than two	CARDINAL
dpc-4769	102	3	2	CARDINAL
dpc-4769	103	1	tildrakizumab	ORG
dpc-4769	106	1	as early as four weeks	DATE
dpc-4769	106	2	tildrakizumab 200 mg	LAW
dpc-4769	106	3	up to 28 weeks	DATE
dpc-4769	107	1	13	CARDINAL
dpc-4769	109	1	week 16, 44	DATE
dpc-4769	110	1	only 24	CARDINAL
dpc-4769	110	2	44	CARDINAL
dpc-4769	110	3	week 16	DATE
dpc-4769	111	1	1	CARDINAL
dpc-4769	111	2	nb	ORG
dpc-4769	112	1	54	CARDINAL
dpc-4769	112	2	36	DATE
dpc-4769	112	3	66.7%	PERCENT
dpc-4769	112	4	18	DATE
dpc-4769	112	5	33.3%	PERCENT
dpc-4769	112	6	age (years	DATE
dpc-4769	112	7	52.9 ± 12.6	CARDINAL
dpc-4769	112	8	18.3 ±	MONEY
dpc-4769	112	9	10.9	CARDINAL
dpc-4769	112	10	13	CARDINAL
dpc-4769	112	11	24%	PERCENT
dpc-4769	112	12	9	CARDINAL
dpc-4769	112	13	16.7%	PERCENT
dpc-4769	112	14	3	CARDINAL
dpc-4769	112	15	5.5%	PERCENT
dpc-4769	112	16	10	CARDINAL
dpc-4769	112	17	18.5%	PERCENT
dpc-4769	112	18	14	DATE
dpc-4769	112	19	25.9%	PERCENT
dpc-4769	112	20	11	DATE
dpc-4769	112	21	20.3%	PERCENT
dpc-4769	112	22	27 (50%	PERCENT
dpc-4769	112	23	30	DATE
dpc-4769	112	24	55.6%	PERCENT
dpc-4769	112	25	28	DATE
dpc-4769	112	26	51.8%	PERCENT
dpc-4769	112	27	8	DATE
dpc-4769	112	28	14.8%	PERCENT
dpc-4769	112	29	1 (1.8%	PERCENT
dpc-4769	112	30	6	CARDINAL
dpc-4769	112	31	11.1%	PERCENT
dpc-4769	112	32	3	CARDINAL
dpc-4769	112	33	5.6%	PERCENT
dpc-4769	112	34	5	CARDINAL
dpc-4769	112	35	9.3%	PERCENT
dpc-4769	112	36	nb	ORG
dpc-4769	112	37	16	CARDINAL
dpc-4769	112	38	29.6%	PERCENT
dpc-4769	112	39	31	DATE
dpc-4769	112	40	57.4%	PERCENT
dpc-4769	112	41	19	DATE
dpc-4769	112	42	35.2%	PERCENT
dpc-4769	112	43	16	DATE
dpc-4769	112	44	29.6%	PERCENT
dpc-4769	112	45	13	CARDINAL
dpc-4769	112	46	24.1%	PERCENT
dpc-4769	112	47	secukinumab ixekizumab brodalumab bimekizumab anti-il-23	PERSON
dpc-4769	112	48	risankizumab guselkumab	PERSON
dpc-4769	112	49	19	CARDINAL
dpc-4769	112	50	35.2%	PERCENT
dpc-4769	112	51	5	CARDINAL
dpc-4769	112	52	9.3%	PERCENT
dpc-4769	112	53	2	CARDINAL
dpc-4769	112	54	3.7%	PERCENT
dpc-4769	112	55	2	CARDINAL
dpc-4769	112	56	3.7%	PERCENT
dpc-4769	112	57	0 9	DATE
dpc-4769	112	58	16.7%	PERCENT
dpc-4769	112	59	7	DATE
dpc-4769	112	60	12.9%	PERCENT
dpc-4769	112	61	3	CARDINAL
dpc-4769	112	62	5.6%	PERCENT
dpc-4769	112	63	3	CARDINAL
dpc-4769	112	64	5.6%	PERCENT
dpc-4769	112	65	0 3 (	DATE
dpc-4769	112	66	5.6%	PERCENT
dpc-4769	112	67	2	CARDINAL
dpc-4769	112	68	3.7%	PERCENT
dpc-4769	112	69	19 (35.19%	PERCENT
dpc-4769	113	1	5	CARDINAL
dpc-4769	113	2	1	CARDINAL
dpc-4769	114	1	bsa	ORG
dpc-4769	115	1	2	CARDINAL
dpc-4769	115	2	week 16	DATE
dpc-4769	116	1	95%	PERCENT
dpc-4769	118	1	6	CARDINAL
dpc-4769	120	1	tildrakizumab 200 mg	LAW
dpc-4769	121	1	tildrakizumab 200 mg	LAW
dpc-4769	123	1	week 16	DATE
dpc-4769	124	1	firstly	ORDINAL
dpc-4769	124	2	30	CARDINAL
dpc-4769	124	3	week 16	DATE
dpc-4769	125	1	tildrakizumab	PERSON
dpc-4769	126	1	tildrakizumab	PERSON
dpc-4769	126	2	27	CARDINAL
dpc-4769	127	1	≥ 90 kg	QUANTITY
dpc-4769	127	2	14	CARDINAL
dpc-4769	128	1	second	ORDINAL
dpc-4769	128	2	greater than two years	DATE
dpc-4769	130	1	risankizumab	PERSON
dpc-4769	130	2	guselkumab	PERSON
dpc-4769	132	1	29	CARDINAL
dpc-4769	132	2	years	DATE
dpc-4769	135	1	tildrakizumab	PERSON
dpc-4769	136	1	100 mg	QUANTITY
dpc-4769	136	2	200	CARDINAL
dpc-4769	138	1	2	CARDINAL
dpc-4769	139	1	bilal j et al	PERSON
dpc-4769	139	2	17	CARDINAL
dpc-4769	141	1	51.8%	PERCENT
dpc-4769	143	1	18-20	CARDINAL
dpc-4769	145	1	21,22	CARDINAL
dpc-4769	150	1	tnf	CARDINAL
dpc-4769	151	1	25	CARDINAL
dpc-4769	152	1	tildrakizumab 200 mg	LAW
dpc-4769	153	1	9,13	CARDINAL
dpc-4769	154	1	aes	ORG
dpc-4769	155	1	bsa	ORG
dpc-4769	158	1	7 18;10(11):2968	DATE
dpc-4769	159	1	10.3390	CARDINAL
dpc-4769	160	1	36428539	DATE
dpc-4769	161	1	visconti mj	PERSON
dpc-4769	161	2	bashyam	PERSON
dpc-4769	161	3	feldman sr.	PERSON
dpc-4769	164	1	2019	DATE
dpc-4769	165	1	10.2217	CARDINAL
dpc-4769	166	1	2019	CARDINAL
dpc-4769	167	1	31512930	CARDINAL
dpc-4769	168	1	ahmad	PERSON
dpc-4769	168	2	mh	ORG
dpc-4769	168	3	mohd	PERSON
dpc-4769	168	4	hussein	PERSON
dpc-4769	170	1	2009;33(7):516-24	CARDINAL
dpc-4769	170	2	10.1080/07434610902744074	CARDINAL
dpc-4769	171	1	pmid	PERSON
dpc-4769	171	2	19639508	DATE
dpc-4769	172	1	8	CARDINAL
dpc-4769	173	1	mahil	PERSON
dpc-4769	175	1	semin immunopathol	PERSON
dpc-4769	176	1	2016	CARDINAL
dpc-4769	176	2	jan;38(1):11-27	EVENT
dpc-4769	177	1	10.1007	CARDINAL
dpc-4769	177	2	0539-8	DATE
dpc-4769	178	1	2015 nov 16	DATE
dpc-4769	179	1	26573299	DATE
dpc-4769	180	1	9	CARDINAL
dpc-4769	180	2	reich k	PERSON
dpc-4769	180	3	papp ka	PERSON
dpc-4769	180	4	tildrakizumab	PERSON
dpc-4769	180	5	1	CARDINAL
dpc-4769	180	6	2	CARDINAL
dpc-4769	180	7	two	CARDINAL
dpc-4769	180	8	3	CARDINAL
dpc-4769	181	1	lancet	ORG
dpc-4769	182	1	2017;390(10091):276	CARDINAL
dpc-4769	183	1	10.1016	CARDINAL
dpc-4769	183	2	6736(17)31279-5	CARDINAL
dpc-4769	184	1	28596043	DATE
dpc-4769	185	1	10	CARDINAL
dpc-4769	185	2	di brizzi ev	PERSON
dpc-4769	185	3	benvenuto p	GPE
dpc-4769	185	4	tildrakizumab	PERSON
dpc-4769	185	5	italian	NORP
dpc-4769	187	1	2023	CARDINAL
dpc-4769	187	2	oct 1;13(4):e2023215	DATE
dpc-4769	188	1	10.5826	CARDINAL
dpc-4769	189	1	pmid	PERSON
dpc-4769	189	2	37992389	DATE
dpc-4769	190	1	11	CARDINAL
dpc-4769	191	1	ema	ORG
dpc-4769	192	1	ilumetri	PERSON
dpc-4769	193	1	european	NORP
dpc-4769	194	1	2018	DATE
dpc-4769	196	1	10	CARDINAL
dpc-4769	197	1	12	CARDINAL
dpc-4769	198	1	papp k	PERSON
dpc-4769	198	2	thaçi	GPE
dpc-4769	198	3	reich k	PERSON
dpc-4769	198	4	tildrakizumab	PERSON
dpc-4769	198	5	iib	PRODUCT
dpc-4769	199	1	j derma tol	PERSON
dpc-4769	200	1	2015;173(4):930–939	PERSON
dpc-4769	200	2	10.1111	CARDINAL
dpc-4769	201	1	pmid	PERSON
dpc-4769	201	2	26042589	DATE
dpc-4769	202	1	13	CARDINAL
dpc-4769	203	1	kokolakis g	PERSON
dpc-4769	203	2	kreis g	PERSON
dpc-4769	204	1	200 mg/2 ml	QUANTITY
dpc-4769	206	1	2022	CARDINAL
dpc-4769	207	1	10.1007	CARDINAL
dpc-4769	208	1	2022	CARDINAL
dpc-4769	208	2	aug 19	DATE
dpc-4769	209	1	35984626	DATE
dpc-4769	210	1	14	CARDINAL
dpc-4769	211	1	tildrakizumab 200 mg	LAW
dpc-4769	211	2	tildrakizumab 100 mg	PERSON
dpc-4769	211	3	above 90	CARDINAL
dpc-4769	211	4	16-week	DATE
dpc-4769	211	5	italian	NORP
dpc-4769	212	1	j dermatolog	PERSON
dpc-4769	213	1	2024	CARDINAL
dpc-4769	213	2	10.1080/09546634.2024.2350760	CARDINAL
dpc-4769	214	1	2024 may 7	DATE
dpc-4769	215	1	38714323	DATE
dpc-4769	216	1	15	CARDINAL
dpc-4769	216	2	narcisi	PERSON
dpc-4769	216	3	valenti m	PERSON
dpc-4769	217	1	52-week	DATE
dpc-4769	217	2	italian	NORP
dpc-4769	219	1	2023	CARDINAL
dpc-4769	220	1	10.1111/jdv.18594	MONEY
dpc-4769	221	1	2022	CARDINAL
dpc-4769	221	2	oct 5	DATE
dpc-4769	222	1	36156312	DATE
dpc-4769	223	1	16	CARDINAL
dpc-4769	224	1	ruggiero	PERSON
dpc-4769	225	1	opin drug	PERSON
dpc-4769	225	2	2022	CARDINAL
dpc-4769	225	3	1451	CARDINAL
dpc-4769	226	1	10.1080/14740338.2022.2160447	CARDINAL
dpc-4769	227	1	2022	CARDINAL
dpc-4769	227	2	dec 28	DATE
dpc-4769	228	1	36527300	CARDINAL
dpc-4769	230	1	bilal j	PERSON
dpc-4769	230	2	bhattacharjee s	PERSON
dpc-4769	236	1	tildrakizumab	ORG
dpc-4769	237	1	bsa	ORG
dpc-4769	237	2	the first few weeks	DATE
dpc-4769	240	1	1	CARDINAL
dpc-4769	240	2	parisi r	PERSON
dpc-4769	240	3	griffiths ce	PERSON
dpc-4769	240	4	ashcroft dm	PERSON
dpc-4769	243	1	2013	DATE
dpc-4769	244	1	10.1038	CARDINAL
dpc-4769	245	1	2012	DATE
dpc-4769	246	1	23014338	CARDINAL
dpc-4769	247	1	2	CARDINAL
dpc-4769	247	2	ghoreschi k	PERSON
dpc-4769	247	3	enerbäck	ORG
dpc-4769	247	4	r.	NORP
dpc-4769	248	1	lancet	ORG
dpc-4769	249	1	2021	CARDINAL
dpc-4769	249	2	397(10275):754-766	CARDINAL
dpc-4769	250	1	10.1016	CARDINAL
dpc-4769	251	1	33515492	CARDINAL
dpc-4769	252	1	3	CARDINAL
dpc-4769	252	2	griffiths ce	PERSON
dpc-4769	255	1	lancet	ORG
dpc-4769	256	1	2007	DATE
dpc-4769	256	2	jul 21;370(9583):263-271	DATE
dpc-4769	257	1	10.1016	CARDINAL
dpc-4769	257	2	6736(07)61128-3	CARDINAL
dpc-4769	258	1	17658397	DATE
dpc-4769	259	1	chiu mw	PERSON
dpc-4769	260	1	clin	ORG
dpc-4769	260	2	investig	GPE
dpc-4769	261	1	2014	DATE
dpc-4769	261	2	17;7:119-32	DATE
dpc-4769	262	1	10.2147	CARDINAL
dpc-4769	263	1	pmid	PERSON
dpc-4769	263	2	24790463	DATE
dpc-4769	264	1	5	CARDINAL
dpc-4769	264	2	di brizzi ev	PERSON
dpc-4769	264	3	rocco	PERSON
dpc-4769	264	4	babino g	GPE
dpc-4769	264	5	calprotectin	PRODUCT
dpc-4769	266	1	2022	CARDINAL
dpc-4769	266	2	nov 8	DATE
dpc-4769	267	1	24	CARDINAL
dpc-4769	268	1	paroutoglou k	PERSON
dpc-4769	268	2	christodoulatos gs	PERSON
dpc-4769	268	3	dalamaga m. deciphering the association	PERSON
dpc-4769	269	1	curr	PERSON
dpc-4769	269	2	2020	DATE
dpc-4769	269	3	178	CARDINAL
dpc-4769	270	1	10.1007	CARDINAL
dpc-4769	270	2	020-00380-3	CARDINAL
dpc-4769	271	1	32418186	CARDINAL
dpc-4769	272	1	25	CARDINAL
dpc-4769	272	2	turkey	GPE
dpc-4769	274	1	2022	CARDINAL
dpc-4769	274	2	may;33(3):1531-1537	ORG
dpc-4769	275	1	10.1080/09546634	CARDINAL
dpc-4769	276	1	2020 nov 1	DATE
dpc-4769	277	1	33074062	DATE
dpc-4769	278	1	26	CARDINAL
dpc-4769	279	1	carrascosa jm	PERSON
dpc-4769	279	2	rocamora v	PERSON
dpc-4769	280	1	actas dermosifiliogr	PERSON
dpc-4769	281	1	2014	DATE
dpc-4769	282	1	english	LANGUAGE
dpc-4769	282	2	spanish	NORP
dpc-4769	283	1	10.1016	CARDINAL
dpc-4769	284	1	2012 nov 23	DATE
dpc-4769	285	1	23177976	DATE
dpc-4769	286	1	27	CARDINAL
dpc-4769	287	1	puig l.	PERSON
dpc-4769	289	1	2011	DATE
dpc-4769	290	1	10.1111	CARDINAL
dpc-4769	291	1	2011	DATE
dpc-4769	291	2	15	CARDINAL
dpc-4769	292	1	21492252	CARDINAL
dpc-4769	293	1	28	CARDINAL
dpc-4769	295	1	italian	NORP
dpc-4769	297	1	2024	CARDINAL
dpc-4769	297	2	10.1111	CARDINAL
dpc-4769	298	1	2023 aug 29	DATE
dpc-4769	299	1	37611277	CARDINAL
dpc-4769	300	1	29	CARDINAL
dpc-4769	301	1	schäkel k	PERSON
dpc-4769	301	2	reich k	PERSON
dpc-4769	302	1	week 28	DATE
dpc-4769	304	1	2023	CARDINAL
dpc-4769	304	2	2027	CARDINAL
dpc-4769	305	1	10.1111	CARDINAL
dpc-4769	306	1	2023	CARDINAL
dpc-4769	306	2	jul 18	DATE
dpc-4769	307	1	37262309	DATE
dpc-4769	308	1	secukinumab	PERSON
dpc-4769	308	2	ixekizumab	PERSON
dpc-4769	308	3	guselkumab	PERSON
dpc-4769	308	4	tildrakizumab	PERSON
dpc-4769	309	1	j dermatolog	PERSON
dpc-4769	310	1	2018	DATE
dpc-4769	310	2	578	CARDINAL
dpc-4769	311	1	10.1080/09546634.2017.1422591	CARDINAL
dpc-4769	312	1	2018	DATE
dpc-4769	313	1	29532693	CARDINAL
dpc-4769	314	1	18	CARDINAL
dpc-4769	316	1	first	ORDINAL
dpc-4769	318	1	346	CARDINAL
dpc-4769	319	1	10.1159/000513398	CARDINAL
dpc-4769	320	1	2021 feb 3	DATE
dpc-4769	320	2	33535213	CARDINAL
dpc-4769	321	1	19	CARDINAL
dpc-4769	322	1	kaushik sb	PERSON
dpc-4769	322	2	lebwohl mg	PERSON
dpc-4769	324	1	j am	PERSON
dpc-4769	325	1	2019	CARDINAL
dpc-4769	326	1	10.1016	CARDINAL
dpc-4769	327	1	2018 jul 11	DATE
dpc-4769	328	1	30017705	DATE
dpc-4769	329	1	20	CARDINAL
dpc-4769	330	1	jensen p	PERSON
dpc-4769	330	2	skov l. psoriasis	PERSON
dpc-4769	332	1	2016;232(6):633-639	CARDINAL
dpc-4769	333	1	10.1159/000455840	CARDINAL
dpc-4769	334	1	2017 feb 23	DATE
dpc-4769	335	1	28226326.	DATE
dpc-4769	336	1	barros g	PERSON
dpc-4769	336	2	duran p	PERSON
dpc-4769	337	1	j mol sci	PERSON
dpc-4769	337	2	2022	CARDINAL
dpc-4769	337	3	10.3390	CARDINAL
dpc-4769	338	1	35886846	DATE
dpc-4769	339	1	22	CARDINAL
dpc-4769	340	1	placek w. compounds	PERSON
dpc-4769	342	1	2017	CARDINAL
dpc-4769	342	2	24;71(1):761-772	CARDINAL
dpc-4769	342	3	10.5604/01.3001.0010.3854	DATE
dpc-4769	343	1	28894050	DATE
dpc-4769	344	1	23	CARDINAL
dpc-4769	345	1	girolomoni g.	PERSON
dpc-4769	346	1	opin pharmacother	PERSON
dpc-4769	347	1	2019	CARDINAL
dpc-4769	347	2	872	CARDINAL
dpc-4769	349	1	2019 feb 22	DATE
dpc-4769	350	1	30794469	DATE